Home Authors Posts by

Caterina Lucchini

19 POSTS

Clinical trials. Two years of PRIME

Virtual trial

Industry embraces the virtual trial platforms

Amazon’s first steps into the business of life sciences

Negative topline results of intepirdine phase 3 MINDSET trial in Alzheimer’s...

Alzheimer’s disease: trigriluzole phase 2 trial in collaboration with ADCS

NBTXR3 will be tested in combination with immune checkpoints inhibitors

Good results for a phase I/II head and neck cancer trial

Results of the antibiotic cadazolid

Chinese cell therapy effective in small multiple myeloma trial

New vaccine to protect adolescent and adult from Men B

12Page 1 of 2

Newsstand

  • Supplement to n.5 - October 2025 NCF International n.2 - 2025
  • NCF International n.1 - 2025
  • Supplemento to n.9 - October 2024 NCF International n.3 - 2024
Newsstand
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151